Potassium channels participate in gastric mucosal protection in rats with partial portal vein ligation.
Glybenclamide, an adenosine triphosphate-dependent potassium (K+(ATP)) channel blocker, lowered portal pressure and attenuated the hyperdynamic splanchnic circulation in rats with partial portal vein ligation (PPVL). The purpose of this report was to confirm these observations and to test the hypothesis that glybenclamide could reduce acidified ethanol-induced gastric mucosal injury in rats with PPVL. Gastric mucosal blood flow (hydrogen gas clearance), systemic blood pressure, and portal pressure were monitored in rats with PPVL or sham operation (SO). Intravenous glybenclamide (20 mg/kg) or vehicle was administered, followed by intragastric acidified ethanol (0.15 N HCl and 15% ethanol). The area of gastric mucosal lesions was assessed by image analysis. In contrast to published findings, there was no significant elevation of portal pressure after glybenclamide administration in rats with PPVL. Glybenclamide did not alter the gastric mucosal hyperemia in these rats. Glybenclamide significantly increased mucosal injury. The data are consistent with the hypothesis that K+(ATP) channels play a role in protecting the gastric mucosa in rats with PPVL.
Li
M K
MK
Department of Medicine, Chinese University of Hong Kong, Hong Kong.
Tsui
C P
CP
Sung
J J
JJ
Scremin
O U
OU
Leung
F W
FW
D000818:Animals; D001794:Blood Pressure; D005753:Gastric Mucosa / Q000098:blood supply / Q000473:pathology* / Q000503:physiopathology*; D005905:Glyburide / Q000494:pharmacology*; D006973:Hypertension / Q000473:pathology / Q000503:physiopathology; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D008297:Male; D011169:Portal Vein / Q000473:pathology*; D015221:Potassium Channels / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012039:Regional Blood Flow
D007004:Hypoglycemic Agents; D015221:Potassium Channels; D005905:Glyburide